|
|
|
|
Integrating Process Analytical Technology (PAT) into validated GMP environments demands more than just technical know-how. Learn about the critical role PAT plays in antibody-drug conjugate (ADC) manufacturing, highlighting the challenges and considerations that come with embedding it into GMP workflows.
|
|
|
|
|
PAT is reshaping how ADCs are developed—bringing speed, precision, and consistency to a traditionally complex process. Uncover how PAT tools are being integrated into ADC platforms to streamline workflows, improve data integrity, and ensure product quality.
|
|
|
|
|
Gain a deeper understanding of how PAT is being applied to antibody-drug conjugate and bioconjugation workflows with this expert-led resource that examines the practicalities of implementing PAT to improve process control and product quality.
|
|
|
|
|
|
|
Discover a trusted CDMO partner with more than 15 years of industry-leading experience in conjugation and purpose-built manufacturing facilities. Explore end-to-end services to help bring your ADCs and bioconjugates into the clinic and to commercialization.
|
|
|
|
|
|
ADC And Bioconjugation CDMO Services
|
Antibody-drug conjugates (ADCs) have ignited a new era of targeted cancer therapies but there are several obstacles and complexities to overcome to bring these therapies to market. To solve the challenges and ensure success of your ADC project, you can rely on an industry-leading CDMO partner with 15+ years experience and focused expertise to meet your ADC development and manufacturing needs, from pre-clinical to commercial. Learn more.
|
|
|
